Renin-angiotensin-aldosterone system blockers after KDIGO stage 3 acute kidney injury: use and impact on 2-year mortality in the AKIKI trial
oleh: Mathilde Scarton, Anne Oppenheimer, Khalil Chaïbi, Didier Dreyfuss, Stéphane Gaudry
| Format: | Article |
|---|---|
| Diterbitkan: | BMC 2019-04-01 |
Deskripsi
No description available for this item.